Overactive bladder (OAB) afflicts hundreds of millions of adults worldwide, and an effective if underused third-line treatment is neuromodulation. The longtime market-dominant devices, Medtronic PLC’s InterStim and Cogentix Medical Inc.’s Urgent PC, now face competition from companies developing alternative approaches to neuromodulation for OAB and other urological indications. These companies see a multibillion-dollar market consisting largely of previously untreated patients.
InterStim, sometimes called the “bladder pacemaker,” is an implanted stimulator of the sacral nerve (sacral neuromodulation, or SNM). Urgent PC...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?